Treatment

test

North American Educational Forum on Lymphoma, 2010 Announced

The North American Educational Forum on Lymphoma is the most comprehensive lymphoma-specific educational conference in North America! This 2 ½ day program provides people with lymphoma and their loved ones with critical information about making the best decisions on treatment options, patient support issues and the latest in lymphoma research.

Free teleconferences: Newly Diagnosed and Advancing Therapies for Blood Cancers

NHL: A Guide to Treatment for the Newly Diagnosed

Location:
Free Teleconference/Webcast
Date: June 15, 2010 - Tuesday

Beginning Time: 12:00 pm Eastern
End Time: 1:30 pm
Event Description:

Register for this free telephone/webcast education program. This program will feature John P. Leonard, MD, The Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY.

Participants will have the opportunity to ask the presenter questions during the program.

Medicare Mailing Checks to Pay for Drugs

Medicare will begin mailing out tens of thousands of $250 checks today to senior citizens throughout the country as part of the Obama administration’s recently enacted health reform law.

Petition to Allow Omacetaxine as Treatment for CL

I recently read about a woman's story on Empowerher and I wanted to share how you can help. Nope - no donation required.

UK Woman Seeks Help

Heather Parkinson, 27, of Queensway, Leyland, has Hodgkin’s Lymphoma, a type of cancer affecting the lymphatic system, and doctors believe the only way forward is a trial treatment being run at London’s Royal Free Hospital, which would cost the primary care trust a one-off £3,000.

But after keeping Heather hanging on for 13 weeks while they made up their minds, health bosses at NHS Central Lancashire devastated her by refusing to fund the treatment, citing the fact that the drug was not yet licensed or proven to work as their reason.

FDA Releases 1st Therapeutic Cancer Vaccine

The field of cancer immunotherapy received an important boost last week with the FDA’s approval of the first therapeutic cancer vaccine, sipuleucel-T (Provenge). The vaccine was approved for some men with metastatic prostate cancer based on the results of a phase III randomized trial. However, because of the way in which the vaccine is produced, its availability will be very limited for at least the next 12 months.

Upcoming Free Teleconferences

Childhood Leukemia and Lymphoma: Update on Treatment and Follow-up Care
Tuesday May 4, 2010
1:00 pm - 2:00 pm Eastern

Register for this free telephone/webcast education program. This program will feature Sima Jeha, MD, Director, Leukemia/Lymphoma, Developmental Therapeutics, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN. Participants will have the opportunity to ask the presenter questions during the program. This program is supported by The Leukemia & Lymphoma Society.

FDA Confronts GlaxoKline Smith about Misleading Cancer Drug Ad

It’s hard to feel too sympathetic to a pharma company and today is no exception. On Friday, the Food and Drug Administration said an advertisement for a GlaxoSmithKline PLC cancer drug was "false or misleading."
Specifically, an advertisement that ran in a cancer medical journal involving Glaxo's drug Arzerra omitted "important information about the drug's safety and effectiveness," the FDA said in a letter to the company that was posted on the agency's Web site.

Alternative Prom with a Purpose

I love prom time. Every Spring, my husband and I will be out to dinner and we'll catch a glimpse of nervous guys decked out in tuxes and girls in sparkly dresses playing grown-up for the night.

It's been a while since my prom. About 20 years ago, actually. And I don't remember how much my dress was, but I'm sure it was a wad of cash for my folks. But I just read on MSN that Your Prom magazine said its poll of national readers, found the average price tag was over $1,000, with boys spending $545 and girls $530.

Yikes!

B lymphocyte cells targeted in new research

Non-profit patient support groups are incredible. They do so much for patients and caregivers, but I love it when organizations cut out the middle-man and do some innovative work directly with biotech firms.

This just in: